Dr. Arif R. Sarwari, MD

Dr. Sarwari practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. Sarwari's NPI, 1679687172, was assigned on August 19, 2006. Dr. Sarwari holds West Virginia license 17948.

Dr. Sarwari's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. Sarwari's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. Sarwari is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Sarwari to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarwari practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sarwari's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sarwari is licensed in West Virginia.

CMS data shows 175 Medicare services from Dr. Sarwari across 6 procedure codes in 2024, for 139 Medicare patients. Medicare paid $12,194 for them.

CMS counts 139 Medicare patients who saw Dr. Sarwari in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarwari's median patient age at 61, with 36% women.

In 2024, Dr. Sarwari wrote 464 Medicare Part D claims for 42 patients. 23% of them were for generic drugs. CMS names the drug for 373 of them, across 10 drugs with 11 or more claims each, at $1,141,325 in total drug cost. In 2023, CMS named 353 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Sarwari for performance year 2024, reported through an alternative payment model (APM). Dr. Sarwari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarwari as offering telehealth.

Dmand AI links 23 papers to Dr. Sarwari, published from 2011 to 2023. 2021 was the busiest year, with 5. The most frequent topics are COVID-19, Anti-Bacterial Agents and HIV Infections. Dr. Sarwari has published most often in W V Med J. Dr. Sarwari's most frequent co-authors are Justin T. Kupec, MD, Dhairya A. Lakhani, MD and Armaghan-E-Rehman Mansoor, MD.

Dmand AI links Dr. Sarwari to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Endocarditis and Heart Diseases.

CMS Open Payments shows 1 general payment to Dr. Sarwari from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $77.